AMLODIPINE

AMLODIPINE was reported 272638 times

These side effects are most commonly reported by patients taking AMLODIPINE:

# Side effect Count
0 FATIGUE 16575
1 DIARRHOEA 14881
2 NAUSEA 14108
3 DYSPNOEA 13790
4 DRUG INEFFECTIVE 12842
5 OFF LABEL USE 12063
6 DIZZINESS 11278
7 HEADACHE 10422
8 ACUTE KIDNEY INJURY 9956
9 PAIN 9610
10 VOMITING 9272
11 FALL 8925
12 ASTHENIA 8849
13 HYPOTENSION 8782
14 MALAISE 8330
15 HYPERTENSION 8229
16 DEATH 8171
17 ARTHRALGIA 8069
18 PNEUMONIA 7921
19 COUGH 6738
20 RASH 6625
21 TOXICITY TO VARIOUS AGENTS 6620
22 BLOOD PRESSURE INCREASED 6537
23 PAIN IN EXTREMITY 6462
24 DRUG INTERACTION 6228
25 PRURITUS 6226
26 WEIGHT DECREASED 6221
27 DECREASED APPETITE 6058
28 PYREXIA 5943
29 CONSTIPATION 5590
30 COMPLETED SUICIDE 5565
31 PERIPHERAL SWELLING 5440
32 CHRONIC KIDNEY DISEASE 5425
33 RENAL FAILURE 5339
34 ABDOMINAL PAIN 5103
35 ANAEMIA 4923
36 CONDITION AGGRAVATED 4785
37 BACK PAIN 4766
38 OEDEMA PERIPHERAL 4622
39 INSOMNIA 4543
40 ANXIETY 4506
41 CHEST PAIN 4481
42 JOINT SWELLING 4328
43 CONFUSIONAL STATE 4219
44 GAIT DISTURBANCE 4134
45 URINARY TRACT INFECTION 4100
46 MYALGIA 3959
47 MUSCLE SPASMS 3946
48 ABDOMINAL PAIN UPPER 3865
49 SOMNOLENCE 3744
50 FEELING ABNORMAL 3623
51 DEHYDRATION 3610
52 WEIGHT INCREASED 3512
53 INTENTIONAL OVERDOSE 3454
54 DEPRESSION 3407
55 ABDOMINAL DISCOMFORT 3318
56 OVERDOSE 3312
57 RENAL IMPAIRMENT 3295
58 CEREBROVASCULAR ACCIDENT 3183
59 ATRIAL FIBRILLATION 3164
60 PRODUCT DOSE OMISSION ISSUE 3130
61 NASOPHARYNGITIS 3116
62 ALOPECIA 3014
63 HYPONATRAEMIA 2984
64 SYNCOPE 2946
65 COVID-19 2915
66 TREMOR 2913
67 PALPITATIONS 2883
68 PARAESTHESIA 2859
69 HAEMOGLOBIN DECREASED 2837
70 MUSCULAR WEAKNESS 2818
71 ERYTHEMA 2796
72 BLOOD CREATININE INCREASED 2771
73 BRADYCARDIA 2764
74 BLOOD GLUCOSE INCREASED 2749
75 PRODUCT USE IN UNAPPROVED INDICATION 2737
76 LOSS OF CONSCIOUSNESS 2725
77 HYPOAESTHESIA 2585
78 SEPSIS 2541
79 GENERAL PHYSICAL HEALTH DETERIORATION 2502
80 VISION BLURRED 2423
81 BALANCE DISORDER 2407
82 MYOCARDIAL INFARCTION 2402
83 ASTHMA 2397
84 HYPOKALAEMIA 2361
85 CHEST DISCOMFORT 2352
86 DRUG HYPERSENSITIVITY 2345
87 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2276
88 PRODUCT USE ISSUE 2256
89 CONTUSION 2251
90 PLATELET COUNT DECREASED 2242
91 MEMORY IMPAIRMENT 2185
92 HYPERSENSITIVITY 2172
93 ABDOMINAL DISTENSION 2167
94 METABOLIC ACIDOSIS 2162
95 DYSPEPSIA 2139
96 HEART RATE INCREASED 2132
97 GASTROINTESTINAL HAEMORRHAGE 2129
98 INFLUENZA 2067
99 DYSPHAGIA 2057
100 CARDIAC ARREST 2047
101 RESPIRATORY FAILURE 2016
102 HYPERHIDROSIS 2015
103 INFECTION 2003
104 THROMBOCYTOPENIA 2002
105 END STAGE RENAL DISEASE 1989
106 GASTROOESOPHAGEAL REFLUX DISEASE 1981
107 HYPERKALAEMIA 1978
108 DRY MOUTH 1977
109 ARTHRITIS 1971
110 CHILLS 1971
111 URTICARIA 1967
112 INCORRECT DOSE ADMINISTERED 1950
113 CARDIAC FAILURE 1948
114 BLOOD PRESSURE DECREASED 1947
115 SUICIDE ATTEMPT 1925
116 OROPHARYNGEAL PAIN 1896
117 VISUAL IMPAIRMENT 1894
118 WHEEZING 1864
119 PSORIASIS 1854
120 LACTIC ACIDOSIS 1845
121 PLEURAL EFFUSION 1845
122 INJECTION SITE PAIN 1828
123 EPISTAXIS 1823
124 NEUTROPENIA 1815
125 TACHYCARDIA 1813
126 OXYGEN SATURATION DECREASED 1804
127 SHOCK 1794
128 PULMONARY OEDEMA 1791
129 WHITE BLOOD CELL COUNT DECREASED 1784
130 NEUROPATHY PERIPHERAL 1774
131 SWELLING 1763
132 OEDEMA 1752
133 HOSPITALISATION 1738
134 DRUG DOSE OMISSION 1729
135 INTENTIONAL PRODUCT USE ISSUE 1690
136 MUSCULOSKELETAL STIFFNESS 1679
137 HOT FLUSH 1670
138 DYSPNOEA EXERTIONAL 1662
139 FLUSHING 1660
140 MALIGNANT NEOPLASM PROGRESSION 1653
141 SINUSITIS 1643
142 DISEASE PROGRESSION 1637
143 PULMONARY EMBOLISM 1637
144 CARDIAC FAILURE CONGESTIVE 1632
145 ANGIOEDEMA 1597
146 SEIZURE 1594
147 MOBILITY DECREASED 1593
148 HYPOGLYCAEMIA 1579
149 DYSGEUSIA 1563
150 LETHARGY 1557
151 RHEUMATOID ARTHRITIS 1543
152 SWELLING FACE 1537
153 FEBRILE NEUTROPENIA 1530
154 DRUG INTOLERANCE 1526
155 HALLUCINATION 1525
156 DIABETES MELLITUS 1516
157 RHABDOMYOLYSIS 1512
158 PRODUCTIVE COUGH 1504
159 CATARACT 1462
160 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1461
161 DRY SKIN 1446
162 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1445
163 SLEEP DISORDER 1438
164 BLOOD PRESSURE SYSTOLIC INCREASED 1437
165 BRONCHITIS 1423
166 HEART RATE DECREASED 1408
167 HAEMORRHAGE 1391
168 RHINORRHOEA 1368
169 ILLNESS 1347
170 VERTIGO 1345
171 CARDIAC DISORDER 1336
172 GASTROINTESTINAL DISORDER 1325
173 FLUID RETENTION 1320
174 HYPOXIA 1316
175 RENAL INJURY 1314
176 FLATULENCE 1311
177 INTENTIONAL PRODUCT MISUSE 1310
178 HAEMATOCHEZIA 1305
179 RENAL FAILURE ACUTE 1289
180 ALANINE AMINOTRANSFERASE INCREASED 1271
181 CELLULITIS 1269
182 BLISTER 1259
183 DYSPHONIA 1254
184 SKIN EXFOLIATION 1249
185 THROMBOSIS 1244
186 HYPERGLYCAEMIA 1238
187 MEDICATION ERROR 1235
188 BLOOD PRESSURE FLUCTUATION 1232
189 PRODUCT QUALITY ISSUE 1224
190 BURNING SENSATION 1214
191 ORTHOSTATIC HYPOTENSION 1211
192 DEPRESSED LEVEL OF CONSCIOUSNESS 1206
193 INTERSTITIAL LUNG DISEASE 1205
194 MUSCULOSKELETAL PAIN 1203
195 RENAL DISORDER 1199
196 NECK PAIN 1191
197 NASAL CONGESTION 1190
198 POLLAKIURIA 1189
199 STRESS 1176
200 STOMATITIS 1157
201 FEELING HOT 1156
202 PANCYTOPENIA 1149
203 OSTEOARTHRITIS 1145
204 SWOLLEN TONGUE 1141
205 RASH PRURITIC 1138
206 ANGINA PECTORIS 1132
207 RECTAL HAEMORRHAGE 1125
208 THERAPY INTERRUPTED 1112
209 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1111
210 ASPARTATE AMINOTRANSFERASE INCREASED 1102
211 DYSARTHRIA 1098
212 ELECTROCARDIOGRAM QT PROLONGED 1084
213 TUBULOINTERSTITIAL NEPHRITIS 1079
214 ARRHYTHMIA 1066
215 EMOTIONAL DISTRESS 1065
216 LOWER RESPIRATORY TRACT INFECTION 1065
217 INFLUENZA LIKE ILLNESS 1064
218 ACUTE MYOCARDIAL INFARCTION 1063
219 AMNESIA 1063
220 COGNITIVE DISORDER 1057
221 TINNITUS 1055
222 LIP SWELLING 1046
223 INFUSION RELATED REACTION 1042
224 HEPATIC ENZYME INCREASED 1040
225 BLOOD POTASSIUM DECREASED 1036
226 MIGRAINE 1036
227 AGITATION 1029
228 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1026
229 DEEP VEIN THROMBOSIS 1024
230 TRANSIENT ISCHAEMIC ATTACK 1023
231 HYPOMAGNESAEMIA 1004
232 HERPES ZOSTER 981
233 C-REACTIVE PROTEIN INCREASED 980
234 PRODUCT DOSE OMISSION 975
235 ADVERSE DRUG REACTION 974
236 DEPRESSED MOOD 966
237 NEPHROGENIC ANAEMIA 962
238 BONE PAIN 961
239 DISCOMFORT 961
240 DYSURIA 960
241 INFLAMMATION 955
242 DELIRIUM 951
243 TREATMENT NONCOMPLIANCE 942
244 CARDIOGENIC SHOCK 933
245 CARDIO-RESPIRATORY ARREST 928
246 ARTHROPATHY 921
247 SKIN DISCOLOURATION 918
248 LUNG DISORDER 915
249 SUICIDAL IDEATION 908
250 DISORIENTATION 907
251 DISTURBANCE IN ATTENTION 899
252 URINARY RETENTION 894
253 WHITE BLOOD CELL COUNT INCREASED 883
254 HAEMATURIA 878
255 PANCREATITIS 876
256 THROAT IRRITATION 874
257 EYE PAIN 867
258 SPEECH DISORDER 864
259 BLOOD CHOLESTEROL INCREASED 863
260 UNEVALUABLE EVENT 862
261 NEPHROLITHIASIS 850
262 MULTIPLE ORGAN DYSFUNCTION SYNDROME 838
263 PRODUCT SUBSTITUTION ISSUE 833
264 COMA 832
265 MENTAL STATUS CHANGES 820
266 NERVOUSNESS 820
267 THERAPY CESSATION 815
268 CYSTITIS 813
269 HYPOCALCAEMIA 804
270 SKIN ULCER 801
271 CEREBRAL HAEMORRHAGE 798
272 SEPTIC SHOCK 797
273 NO ADVERSE EVENT 787
274 ANAPHYLACTIC REACTION 786
275 SUSPECTED SUICIDE 786
276 CIRCULATORY COLLAPSE 779
277 OSTEOPOROSIS 777
278 PROTEINURIA 774
279 URINARY INCONTINENCE 772
280 CORONARY ARTERY DISEASE 769
281 HYPOTHYROIDISM 767
282 DISTRIBUTIVE SHOCK 766
283 RED BLOOD CELL COUNT DECREASED 762
284 ASCITES 761
285 BLOOD GLUCOSE DECREASED 760
286 EYE IRRITATION 760
287 GOUT 751
288 HEPATIC FUNCTION ABNORMAL 748
289 ADVERSE EVENT 745
290 COLITIS 744
291 INTERNATIONAL NORMALISED RATIO INCREASED 740
292 MELAENA 736
293 HEAD INJURY 734
294 APHASIA 733
295 DISEASE RECURRENCE 732
296 ERECTILE DYSFUNCTION 721
297 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 721
298 RASH ERYTHEMATOUS 720
299 ACUTE RESPIRATORY FAILURE 716
300 LIVER DISORDER 713
301 UPPER RESPIRATORY TRACT INFECTION 712
302 HAEMOPTYSIS 710
303 LIMB DISCOMFORT 710
304 SEROTONIN SYNDROME 708
305 CHOLELITHIASIS 706
306 ECZEMA 705
307 BLOOD PRESSURE ABNORMAL 703
308 PNEUMONIA ASPIRATION 702
309 HAEMATEMESIS 693
310 BLOOD CREATINE PHOSPHOKINASE INCREASED 689
311 CEREBRAL INFARCTION 685
312 HYPERTENSIVE CRISIS 680
313 HYPOPHAGIA 680
314 UPPER GASTROINTESTINAL HAEMORRHAGE 670
315 DIVERTICULITIS 669
316 LEUKOPENIA 667
317 UNDERDOSE 666
318 HAEMATOMA 657
319 INTESTINAL OBSTRUCTION 657
320 FEELING COLD 655
321 TASTE DISORDER 654
322 CROHN^S DISEASE 651
323 HEART RATE IRREGULAR 651
324 PAIN IN JAW 651
325 UNRESPONSIVE TO STIMULI 651
326 DRUG LEVEL INCREASED 649
327 NEUTROPHIL COUNT DECREASED 649
328 DYSSTASIA 647
329 RESTLESSNESS 641
330 BLOOD SODIUM DECREASED 640
331 RESPIRATORY DISTRESS 640
332 DRUG-INDUCED LIVER INJURY 639
333 NIGHTMARE 638
334 DRY EYE 637
335 INJECTION SITE ERYTHEMA 637
336 FAECES DISCOLOURED 636
337 GASTRITIS 636
338 PERICARDIAL EFFUSION 635
339 PANCREATITIS ACUTE 631
340 THERAPY NON-RESPONDER 631
341 HIP FRACTURE 627
342 NIGHT SWEATS 627
343 PRESYNCOPE 625
344 ORAL PAIN 622
345 PLASMA CELL MYELOMA 619
346 GAIT INABILITY 618
347 ENCEPHALOPATHY 613
348 DEVICE ISSUE 612
349 EYE SWELLING 612
350 BLOOD UREA INCREASED 610
351 ALTERED STATE OF CONSCIOUSNESS 604
352 LEUKOCYTOSIS 604
353 SKIN LESION 604
354 BLINDNESS 603
355 ILL-DEFINED DISORDER 603
356 NOCTURIA 603
357 AGEUSIA 602
358 GLOMERULAR FILTRATION RATE DECREASED 595
359 LIVER FUNCTION TEST ABNORMAL 595
360 OCULAR HYPERAEMIA 595
361 RESPIRATORY TRACT INFECTION 594
362 SURGERY 591
363 NEURALGIA 590
364 PNEUMONITIS 590
365 HYPOACUSIS 587
366 HEMIPARESIS 584
367 PULMONARY HYPERTENSION 583
368 RASH MACULAR 583
369 FREQUENT BOWEL MOVEMENTS 582
370 MOVEMENT DISORDER 582
371 BLOOD POTASSIUM INCREASED 581
372 TYPE 2 DIABETES MELLITUS 580
373 INJECTION SITE BRUISING 576
374 DYSKINESIA 572
375 MUCOSAL INFLAMMATION 569
376 ACUTE RESPIRATORY DISTRESS SYNDROME 567
377 CONTRAINDICATED PRODUCT ADMINISTERED 566
378 LYMPHADENOPATHY 562
379 INJECTION SITE HAEMORRHAGE 560
380 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 560
381 ACCIDENTAL OVERDOSE 559
382 EATING DISORDER 557
383 ANHEDONIA 555
384 PALLOR 555
385 GAMMA-GLUTAMYLTRANSFERASE INCREASED 554
386 TREATMENT FAILURE 554
387 HAEMATOCRIT DECREASED 553
388 HALLUCINATION, VISUAL 547
389 HYPERPARATHYROIDISM SECONDARY 547
390 DIABETES MELLITUS INADEQUATE CONTROL 544
391 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 543
392 JAUNDICE 543
393 BLOOD URINE PRESENT 542
394 COLITIS ULCERATIVE 542
395 THERAPEUTIC RESPONSE DECREASED 542
396 GLYCOSYLATED HAEMOGLOBIN INCREASED 541
397 HYPERSOMNIA 538
398 BLOOD ALKALINE PHOSPHATASE INCREASED 536
399 NEOPLASM MALIGNANT 533
400 HEPATIC STEATOSIS 532
401 BLOOD CALCIUM DECREASED 531
402 VASOPLEGIA SYNDROME 530
403 CHROMATURIA 528
404 SLEEP APNOEA SYNDROME 527
405 LIMB INJURY 521
406 MOUTH ULCERATION 521
407 OBSTRUCTIVE AIRWAYS DISORDER 519
408 CHOLESTASIS 518
409 DIPLOPIA 517
410 SEDATION 515
411 DEMENTIA 513
412 DRUG ABUSE 513
413 BASAL CELL CARCINOMA 512
414 GINGIVAL BLEEDING 512
415 LACRIMATION INCREASED 512
416 HAEMORRHOIDS 511
417 POOR QUALITY SLEEP 510
418 LOCALISED INFECTION 508
419 PRODUCT PRESCRIBING ERROR 508
420 BLOOD BILIRUBIN INCREASED 503
421 ISCHAEMIC STROKE 503
422 ACNE 500
423 SNEEZING 499
424 RASH MACULO-PAPULAR 498
425 VIRAL INFECTION 498
426 ROAD TRAFFIC ACCIDENT 496
427 MENTAL DISORDER 494
428 IRRITABILITY 493
429 THERAPEUTIC PRODUCT EFFECT DECREASED 493
430 SKIN DISORDER 491
431 DRUG ERUPTION 485
432 HYPERCALCAEMIA 484
433 PSORIATIC ARTHROPATHY 484
434 HAIR COLOUR CHANGES 483
435 SINUS BRADYCARDIA 483
436 FLUID OVERLOAD 482
437 VASCULITIS 481
438 DEVICE MALFUNCTION 479
439 JOINT STIFFNESS 476
440 EOSINOPHILIA 475
441 WOUND 475
442 CLOSTRIDIUM DIFFICILE INFECTION 474
443 EYE PRURITUS 473
444 NEOPLASM PROGRESSION 472
445 BLOOD PRESSURE DIASTOLIC DECREASED 470
446 SINUS DISORDER 469
447 STAPHYLOCOCCAL INFECTION 467
448 FUNGAL INFECTION 466
449 GASTRIC ULCER 466
450 SUBDURAL HAEMATOMA 466
451 EYE DISORDER 465
452 THERAPEUTIC RESPONSE UNEXPECTED 464
453 DIABETIC KETOACIDOSIS 463
454 BODY TEMPERATURE DECREASED 461
455 GINGIVAL HYPERTROPHY 461
456 INJURY 458
457 RENAL TUBULAR NECROSIS 457
458 IMPAIRED HEALING 456
459 RESPIRATORY DISORDER 455
460 GLAUCOMA 454
461 RIB FRACTURE 454
462 BLOOD PRESSURE INADEQUATELY CONTROLLED 452
463 VISUAL ACUITY REDUCED 450
464 PULMONARY FIBROSIS 448
465 FULL BLOOD COUNT DECREASED 447
466 GASTRIC DISORDER 446
467 PRURITUS GENERALISED 446
468 FEMUR FRACTURE 445
469 INJECTION SITE SWELLING 445
470 RESPIRATORY ARREST 444
471 HAEMODYNAMIC INSTABILITY 443
472 INTERVERTEBRAL DISC PROTRUSION 443
473 MICTURITION URGENCY 441
474 ANURIA 439
475 SINUS CONGESTION 439
476 STEVENS-JOHNSON SYNDROME 436
477 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 435
478 INTENTIONAL DOSE OMISSION 435
479 AGRANULOCYTOSIS 433
480 COORDINATION ABNORMAL 432
481 FOETAL EXPOSURE DURING PREGNANCY 432
482 CHOKING 430
483 ELECTROLYTE IMBALANCE 430
484 HEPATITIS 429
485 MUSCULOSKELETAL CHEST PAIN 428
486 JOINT INJURY 427
487 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 425
488 SYSTEMIC LUPUS ERYTHEMATOSUS 425
489 AGGRESSION 424
490 EPILEPSY 422
491 THIRST 421
492 HYPERLIPIDAEMIA 419
493 PROSTATE CANCER 419
494 BLOOD COUNT ABNORMAL 418
495 INJECTION SITE PRURITUS 418
496 TOXIC EPIDERMAL NECROLYSIS 418
497 HEPATIC FAILURE 417
498 CORONARY ARTERY OCCLUSION 416
499 PANIC ATTACK 416
500 SKIN BURNING SENSATION 416
501 IMPAIRED QUALITY OF LIFE 415
502 LABORATORY TEST ABNORMAL 415
503 MULTIPLE SCLEROSIS RELAPSE 413
504 ABDOMINAL PAIN LOWER 412
505 DEAFNESS 411
506 ACCIDENTAL EXPOSURE TO PRODUCT 409
507 LUNG NEOPLASM MALIGNANT 409
508 MUSCULOSKELETAL DISCOMFORT 409
509 PROSTATIC SPECIFIC ANTIGEN INCREASED 407
510 BREAST CANCER 406
511 DRUG EFFECT DECREASED 404
512 LIVER FUNCTION TEST INCREASED 403
513 CARDIOMEGALY 402
514 HEAD DISCOMFORT 402
515 FEEDING DISORDER 401
516 PULMONARY MASS 401
517 CONVULSION 399
518 HYPOTHERMIA 398
519 RETCHING 396
520 FULL BLOOD COUNT ABNORMAL 395
521 MITRAL VALVE INCOMPETENCE 395
522 IMPAIRED GASTRIC EMPTYING 392
523 TACHYPNOEA 392
524 KIDNEY INFECTION 390
525 RESPIRATORY TRACT CONGESTION 387
526 HIATUS HERNIA 386
527 LIVER INJURY 386
528 LOCAL SWELLING 386
529 GENERALISED OEDEMA 383
530 ULCER 383
531 BLOOD MAGNESIUM DECREASED 380
532 TOOTH DISORDER 380
533 PERIPHERAL COLDNESS 379
534 HAIR TEXTURE ABNORMAL 378
535 RASH GENERALISED 377
536 BLOOD IRON DECREASED 375
537 ATRIOVENTRICULAR BLOCK COMPLETE 374
538 EJECTION FRACTION DECREASED 374
539 PULMONARY ARTERIAL HYPERTENSION 372
540 MIDDLE INSOMNIA 371
541 MUSCLE TWITCHING 371
542 THROAT TIGHTNESS 370
543 TRANSAMINASES INCREASED 369
544 PRODUCT DOSE OMISSION IN ERROR 368
545 DRUG EFFECT INCOMPLETE 366
546 HYPERTHYROIDISM 365
547 NON-CARDIOGENIC PULMONARY OEDEMA 365
548 VENTRICULAR TACHYCARDIA 364
549 GASTROENTERITIS 363
550 DERMATITIS ATOPIC 362
551 ABNORMAL BEHAVIOUR 360
552 INJECTION SITE MASS 360
553 PULMONARY CONGESTION 360
554 SINUS TACHYCARDIA 360
555 BACTERIAL INFECTION 358
556 HYPOKINESIA 355
557 SEASONAL ALLERGY 354
558 NEPHROPATHY 351
559 MATERNAL EXPOSURE DURING PREGNANCY 350
560 SCIATICA 350
561 HEMIPLEGIA 349
562 WITHDRAWAL SYNDROME 349
563 ERUCTATION 347
564 REBOUND ACID HYPERSECRETION 347
565 ANAPHYLACTIC SHOCK 346
566 COAGULOPATHY 346
567 ABNORMAL DREAMS 344
568 PEMPHIGOID 344
569 HERNIA 342
570 PRESCRIBED UNDERDOSE 342
571 PROCEDURAL PAIN 342
572 PRODUCT ADMINISTRATION ERROR 339
573 ARTERIAL OCCLUSIVE DISEASE 338
574 GINGIVAL PAIN 338
575 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 338
576 BREATH SOUNDS ABNORMAL 337
577 APLASTIC ANAEMIA 336
578 HAEMORRHAGE INTRACRANIAL 336
579 MUSCLE SPASTICITY 336
580 INJECTION SITE REACTION 335
581 COLD SWEAT 334
582 SKIN CANCER 334
583 SPUTUM DISCOLOURED 334
584 UPPER LIMB FRACTURE 334
585 BLOOD PRESSURE SYSTOLIC ABNORMAL 333
586 DIZZINESS POSTURAL 333
587 GLOSSODYNIA 333
588 BRONCHIECTASIS 332
589 TRANSFUSION 331
590 URINE OUTPUT DECREASED 331
591 ADRENAL INSUFFICIENCY 330
592 EAR PAIN 330
593 NEPHROPATHY TOXIC 330
594 RED BLOOD CELL SEDIMENTATION RATE INCREASED 330
595 UROSEPSIS 330
596 HYPERCHOLESTEROLAEMIA 329
597 METASTASES TO LIVER 326
598 CREATININE RENAL CLEARANCE DECREASED 325
599 HEPATOTOXICITY 325
600 BLOOD GLUCOSE ABNORMAL 324
601 DERMATITIS 324
602 DIALYSIS 324
603 OLIGURIA 324
604 SKIN HAEMORRHAGE 324
605 CLOSTRIDIUM DIFFICILE COLITIS 323
606 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 323
607 BLOOD LACTATE DEHYDROGENASE INCREASED 322
608 HAIR DISORDER 321
609 KNEE ARTHROPLASTY 320
610 ABASIA 319
611 BODY TEMPERATURE INCREASED 319
612 BLOOD TEST ABNORMAL 318
613 RALES 317
614 THYROID DISORDER 317
615 PARKINSON^S DISEASE 316
616 ACIDOSIS 315
617 EAR INFECTION 315
618 INCREASED APPETITE 315
619 ANGER 314
620 CANDIDA INFECTION 314
621 BODY HEIGHT DECREASED 313
622 MADAROSIS 313
623 MYOPATHY 313
624 RASH PAPULAR 313
625 RESTLESS LEGS SYNDROME 313
626 LEFT VENTRICULAR HYPERTROPHY 312
627 PHOTOSENSITIVITY REACTION 312
628 MOOD ALTERED 311
629 OESOPHAGITIS 311
630 BLOOD PRESSURE DIASTOLIC ABNORMAL 310
631 NERVOUS SYSTEM DISORDER 310
632 BRAIN FOG 309
633 SPINAL FRACTURE 309
634 SUBARACHNOID HAEMORRHAGE 309
635 EXPIRED PRODUCT ADMINISTERED 308
636 BLOOD TRIGLYCERIDES INCREASED 307
637 SECRETION DISCHARGE 307
638 OSTEONECROSIS OF JAW 305
639 PLATELET COUNT INCREASED 305
640 TROPONIN INCREASED 305
641 RENAL CYST 304
642 VENTRICULAR EXTRASYSTOLES 304
643 OSTEOMYELITIS 303
644 IRON DEFICIENCY ANAEMIA 302
645 LYMPHOCYTE COUNT DECREASED 302
646 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 302
647 COVID-19 PNEUMONIA 301
648 CRYING 300
649 HEPATIC CIRRHOSIS 300
650 MUSCLE TIGHTNESS 300
651 ATRIOVENTRICULAR BLOCK FIRST DEGREE 299
652 CYTOKINE RELEASE SYNDROME 299
653 ORAL HERPES 299
654 SMALL INTESTINAL OBSTRUCTION 299
655 THERAPEUTIC RESPONSE SHORTENED 299
656 GENERALISED TONIC-CLONIC SEIZURE 298
657 MUSCLE ATROPHY 298
658 EXTRA DOSE ADMINISTERED 297
659 MYOCARDIAL ISCHAEMIA 297
660 PARAESTHESIA ORAL 297
661 PHOTOPHOBIA 297
662 RHINITIS 297
663 ARTERIOSCLEROSIS 296
664 FOOT FRACTURE 295
665 MENTAL IMPAIRMENT 295
666 OBESITY 295
667 PRODUCT STORAGE ERROR 294
668 BLOOD LACTIC ACID INCREASED 293
669 FIBROMYALGIA 293
670 PETECHIAE 292
671 PHARYNGEAL OEDEMA 292
672 EXPOSURE DURING PREGNANCY 291
673 FEAR 291
674 OSTEOPENIA 290
675 PRODUCT DISPENSING ERROR 290
676 BACTERAEMIA 289
677 MAJOR DEPRESSION 289
678 PSYCHOTIC DISORDER 289
679 CARDIOVASCULAR DISORDER 288
680 CARDIAC MURMUR 287
681 HEPATOCELLULAR INJURY 287
682 ECONOMIC PROBLEM 286
683 MOTOR DYSFUNCTION 286
684 NEEDLE ISSUE 286
685 ORAL CANDIDIASIS 286
686 PNEUMOTHORAX 286
687 RESPIRATORY RATE INCREASED 286
688 BONE DISORDER 285
689 DRUG DOSE OMISSION BY DEVICE 285
690 GASTROENTERITIS VIRAL 285
691 ANKLE FRACTURE 284
692 PHYSICAL DECONDITIONING 284
693 ACUTE CORONARY SYNDROME 283
694 BENIGN PROSTATIC HYPERPLASIA 283
695 POST PROCEDURAL COMPLICATION 283
696 ATELECTASIS 282
697 MUSCULOSKELETAL DISORDER 282
698 PAIN OF SKIN 282
699 BLINDNESS UNILATERAL 281
700 FLANK PAIN 281
701 INTERNAL HAEMORRHAGE 281
702 TOOTHACHE 281
703 HYPOPHOSPHATAEMIA 280
704 PERITONITIS 279
705 VENTRICULAR FIBRILLATION 279
706 ATRIAL FLUTTER 278
707 COLON CANCER 278
708 SPINAL OSTEOARTHRITIS 278
709 EMPHYSEMA 277
710 ILEUS 277
711 IMPAIRED WORK ABILITY 277
712 ROTATOR CUFF SYNDROME 277
713 TENDONITIS 276
714 POLYURIA 275
715 SENSORY LOSS 275
716 SPINAL PAIN 275
717 VAGINAL HAEMORRHAGE 275
718 APATHY 274
719 EMOTIONAL DISORDER 274
720 MYOCLONUS 273
721 PSYCHOLOGICAL TRAUMA 273
722 SEDATION COMPLICATION 272
723 TOOTH INFECTION 272
724 ANAL INCONTINENCE 271
725 ATRIOVENTRICULAR BLOCK 270
726 GROIN PAIN 270
727 CHOLECYSTITIS 269
728 BACK DISORDER 268
729 BONE DENSITY DECREASED 268
730 SENSORY DISTURBANCE 268
731 MULTIPLE SCLEROSIS 267
732 THROMBOTIC MICROANGIOPATHY 267
733 DRUG WITHDRAWAL SYNDROME 266
734 NEUTROPENIC SEPSIS 266
735 FRACTURE 264
736 MALIGNANT MELANOMA 264
737 BLOOD URIC ACID INCREASED 262
738 DEVICE RELATED INFECTION 262
739 SYNOVITIS 262
740 WRONG TECHNIQUE IN DRUG USAGE PROCESS 262
741 CONJUNCTIVITIS 261
742 FEELING JITTERY 261
743 HAEMODIALYSIS 260
744 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 260
745 CARDIAC FAILURE ACUTE 259
746 ELECTROCARDIOGRAM ABNORMAL 258
747 FACE OEDEMA 258
748 GINGIVAL SWELLING 258
749 NEPHROTIC SYNDROME 257
750 SKIN IRRITATION 257
751 MASS 256
752 BRASH SYNDROME 255
753 CARPAL TUNNEL SYNDROME 255
754 HOSPICE CARE 255
755 PROTEIN URINE PRESENT 255
756 SCAR 255
757 ABNORMAL LOSS OF WEIGHT 254
758 RENAL FAILURE CHRONIC 254
759 HYPOVOLAEMIA 253
760 DRUG ADMINISTRATION ERROR 251
761 MOOD SWINGS 251
762 IMMUNODEFICIENCY 250
763 NEUROTOXICITY 250
764 APHONIA 249
765 DELUSION 249
766 LUNG INFECTION 249
767 MYASTHENIA GRAVIS 248
768 PARKINSONISM 248
769 RENAL PAIN 248
770 DISSEMINATED INTRAVASCULAR COAGULATION 247
771 IRRITABLE BOWEL SYNDROME 246
772 EYE HAEMORRHAGE 245
773 MULTI-ORGAN FAILURE 244
774 ASPIRATION 243
775 DECREASED ACTIVITY 243
776 METASTASES TO LUNG 243
777 PRODUCT AVAILABILITY ISSUE 240
778 SUPRAVENTRICULAR TACHYCARDIA 240
779 SPLENOMEGALY 239
780 LOWER LIMB FRACTURE 238
781 LYMPHOPENIA 237
782 SKIN LACERATION 237
783 ABSCESS 236
784 HYPERVOLAEMIA 236
785 MALNUTRITION 236
786 ORAL DISCOMFORT 236
787 PREMATURE BABY 236
788 EXTRAPYRAMIDAL DISORDER 235
789 GANGRENE 235
790 INCORRECT DRUG ADMINISTRATION DURATION 234
791 BOWEL MOVEMENT IRREGULARITY 233
792 PRODUCT PHYSICAL ISSUE 233
793 DIASTOLIC DYSFUNCTION 232
794 TRICUSPID VALVE INCOMPETENCE 232
795 BLOOD PRESSURE DIASTOLIC INCREASED 231
796 SQUAMOUS CELL CARCINOMA 231
797 ACTIVITIES OF DAILY LIVING IMPAIRED 230
798 INCREASED TENDENCY TO BRUISE 230
799 MYOSITIS 230
800 PAROSMIA 230
801 SARS-COV-2 TEST POSITIVE 230
802 VITAMIN D DEFICIENCY 230
803 BONE MARROW FAILURE 229
804 NEUTROPHIL COUNT INCREASED 229
805 UPPER-AIRWAY COUGH SYNDROME 229
806 DRUG PRESCRIBING ERROR 228
807 FAECES SOFT 228
808 LARGE INTESTINE POLYP 228
809 LOWER GASTROINTESTINAL HAEMORRHAGE 228
810 PRESCRIBED OVERDOSE 228
811 AFFECT LABILITY 227
812 ATAXIA 227
813 COLITIS ISCHAEMIC 227
814 GALLBLADDER DISORDER 227
815 INCORRECT PRODUCT ADMINISTRATION DURATION 227
816 PURPURA 227
817 DRY THROAT 226
818 HYDRONEPHROSIS 226
819 RENAL FUNCTION TEST ABNORMAL 226
820 SKIN FISSURES 226
821 BLOOD ALBUMIN DECREASED 225
822 DRUG DEPENDENCE 225
823 HYPOAESTHESIA ORAL 225
824 PHARYNGEAL SWELLING 225
825 QUALITY OF LIFE DECREASED 225
826 PNEUMONIA BACTERIAL 224
827 CARDIOMYOPATHY 223
828 INFUSION SITE PAIN 223
829 HAEMORRHAGIC STROKE 222
830 HEPATOMEGALY 222
831 AORTIC ANEURYSM 221
832 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 221
833 SHOCK HAEMORRHAGIC 221
834 BRAIN OEDEMA 218
835 CARDIOTOXICITY 218
836 CYTOMEGALOVIRUS INFECTION 218
837 POLYP 218
838 WEIGHT FLUCTUATION 217
839 TOOTH FRACTURE 216
840 VITAMIN D DECREASED 216
841 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 216
842 RENAL CANCER 215
843 BLOOD THYROID STIMULATING HORMONE INCREASED 214
844 BURSITIS 214
845 PNEUMOCYSTIS JIROVECII PNEUMONIA 214
846 PYELONEPHRITIS 214
847 THINKING ABNORMAL 214
848 BLOOD CALCIUM INCREASED 212
849 CYTOPENIA 212
850 DIVERTICULUM 212
851 HIP ARTHROPLASTY 212
852 INCONTINENCE 212
853 METASTASES TO BONE 212
854 PARALYSIS 212
855 TENDON RUPTURE 212
856 ANOSMIA 211
857 PHARYNGITIS 211
858 DEVICE DISLOCATION 210
859 PANCREATIC CARCINOMA 210
860 PULMONARY THROMBOSIS 210
861 TOXIC SKIN ERUPTION 210
862 BEDRIDDEN 208
863 BLOOD GLUCOSE FLUCTUATION 208
864 EAR DISCOMFORT 208
865 NODULE 208
866 ARTERIOSCLEROSIS CORONARY ARTERY 207
867 CYANOSIS 207
868 EYELID OEDEMA 207
869 DUODENAL ULCER 206
870 INTERVERTEBRAL DISC DEGENERATION 206
871 MYOCARDITIS 206
872 PRODUCT PRESCRIBING ISSUE 206
873 VITREOUS FLOATERS 206
874 KIDNEY TRANSPLANT REJECTION 205
875 POISONING 205
876 PRODUCT USE COMPLAINT 205
877 FACIAL PAIN 204
878 HALLUCINATION, AUDITORY 204
879 INTESTINAL ISCHAEMIA 204
880 LUNG INFILTRATION 204
881 POOR VENOUS ACCESS 204
882 HYPERKERATOSIS 203
883 TOOTH LOSS 203
884 GINGIVITIS 201
885 JOINT DISLOCATION 201
886 LEFT VENTRICULAR DYSFUNCTION 201
887 HYPOVOLAEMIC SHOCK 200
888 MACULAR DEGENERATION 200
889 POTENTIATING DRUG INTERACTION 200
890 BRONCHOSPASM 199
891 EXTRASYSTOLES 199
892 CYST 198
893 POISONING DELIBERATE 198
894 SPRUE-LIKE ENTEROPATHY 198
895 EXERCISE TOLERANCE DECREASED 197
896 BLOOD PRESSURE SYSTOLIC DECREASED 196
897 HYPERURICAEMIA 196
898 JOINT RANGE OF MOTION DECREASED 196
899 TOOTH ABSCESS 196
900 APPLICATION SITE PRURITUS 195
901 IRON DEFICIENCY 195
902 PERICARDITIS 195
903 PERSONALITY DISORDER 194
904 DEVICE DELIVERY SYSTEM ISSUE 192
905 GASTROINTESTINAL PAIN 192
906 HYPOALBUMINAEMIA 192
907 NERVE INJURY 192
908 WRIST FRACTURE 192
909 ABNORMAL FAECES 191
910 NERVE COMPRESSION 191
911 SPINAL COMPRESSION FRACTURE 191
912 APHTHOUS ULCER 190
913 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 190
914 EYE INFECTION 190
915 RAYNAUD^S PHENOMENON 190
916 TENDERNESS 190
917 PRODUCT TASTE ABNORMAL 189
918 AORTIC STENOSIS 188
919 POST PROCEDURAL HAEMORRHAGE 188
920 BLADDER CANCER 187
921 BUNDLE BRANCH BLOCK RIGHT 187
922 CORONARY ARTERY STENOSIS 187
923 PELVIC FRACTURE 187
924 NEOPLASM 186
925 BLADDER DISORDER 185
926 PRODUCT ADHESION ISSUE 185
927 ERYSIPELAS 184
928 MANIA 184
929 MOUTH HAEMORRHAGE 184
930 ANGINA UNSTABLE 183
931 BUNDLE BRANCH BLOCK LEFT 183
932 HAEMORRHAGIC ANAEMIA 183
933 OSTEONECROSIS 183
934 SPINAL OPERATION 183
935 ECCHYMOSIS 182
936 SKIN INFECTION 182
937 DERMATITIS ALLERGIC 181
938 INTRAOCULAR PRESSURE INCREASED 181
939 LYMPHOEDEMA 181
940 POLYNEUROPATHY 181
941 APPENDICITIS 180
942 DEVICE LEAKAGE 180
943 GLUCOSE TOLERANCE IMPAIRED 180
944 HEPATIC CYTOLYSIS 180
945 INTESTINAL PERFORATION 180
946 PULSELESS ELECTRICAL ACTIVITY 180
947 DIARRHOEA HAEMORRHAGIC 179
948 EXOSTOSIS 179
949 HEPATIC ENCEPHALOPATHY 179
950 MUSCLE RIGIDITY 179
951 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 179
952 DRUG LEVEL DECREASED 178
953 ISCHAEMIA 178
954 MULTIPLE FRACTURES 178
955 PARANOIA 178
956 DRUG RESISTANCE 176
957 LIGAMENT SPRAIN 176
958 PAPULE 176
959 DIVERTICULUM INTESTINAL 175
960 ESCHERICHIA INFECTION 175
961 ORAL DISORDER 175
962 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 174
963 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 174
964 BREAST PAIN 174
965 DECUBITUS ULCER 174
966 FACIAL PARALYSIS 174
967 SCAB 173
968 TUMOUR LYSIS SYNDROME 173
969 ACUTE PULMONARY OEDEMA 172
970 INTENTIONAL DRUG MISUSE 171
971 WOUND INFECTION 171
972 APPLICATION SITE ERYTHEMA 170
973 GASTRIC HAEMORRHAGE 170
974 HAEMOGLOBIN ABNORMAL 170
975 MYELODYSPLASTIC SYNDROME 170
976 OCULAR DISCOMFORT 170
977 COLITIS MICROSCOPIC 169
978 SCRATCH 169
979 SKIN REACTION 169
980 TOOTH EXTRACTION 169
981 CUTANEOUS VASCULITIS 168
982 NEUROLEPTIC MALIGNANT SYNDROME 168
983 STENT PLACEMENT 168
984 URINE ODOUR ABNORMAL 168
985 YELLOW SKIN 168
986 ADJUSTMENT DISORDER 167
987 CAROTID ARTERY STENOSIS 167
988 EOSINOPHIL COUNT INCREASED 167
989 PSYCHOMOTOR HYPERACTIVITY 167
990 ANGIOPATHY 166
991 FOOT DEFORMITY 166
992 INFUSION SITE ERYTHEMA 166
993 MUSCLE STRAIN 166
994 RENAL CELL CARCINOMA 166
995 RIGHT VENTRICULAR FAILURE 166
996 SKIN PLAQUE 166
997 SLUGGISHNESS 166
998 TARDIVE DYSKINESIA 166
999 CAROTID ARTERY THROMBOSIS 165